Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Other Non-Current Liabilities (2024 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed Other Non-Current Liabilities for 2 consecutive years, with $484000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Other Non-Current Liabilities fell 36.4% to $484000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $484000.0, a 36.4% decrease, with the full-year FY2025 number at $484000.0, down 36.4% from a year prior.
  • Other Non-Current Liabilities was $484000.0 for Q4 2025 at Day One Biopharmaceuticals, down from $761000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $761000.0 in Q4 2024 to a low of $484000.0 in Q4 2025.